New Delhi: For many cancer patients in India, advanced treatments such as immunotherapy have long remained financially out of reach. The emergence of biosimilar immunotherapy drugs is now beginning to ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. In this photograph taken on October 5, 2021, farmer and doctor Amit Singh speaks during an ...

GSK India is seeing a larger share of its India business come from oncology therapies, specialty medicines and adult vaccines as multinational drugmakers focus more on high-value therapies in the ...

Researcher develops 'smart, tiny bubbles' to treat cancer and heart disease by Wendy Sarubbi, UCF College of Medicine edited by Sadie Harley, reviewed by Andrew Zinin Editors' notes ...

On May 7, 2026, the Defence Research and Development Organisation (DRDO) and the Indian Air Force (IAF) successfully carried out the maiden flight trial of the Tactical Advanced Range Augmentation ...

Pharma major Roche on Thursday announced the launch of the immunotherapy drug Tecentriq that can, for the first time, be administered subcutaneously, reducing drug delivery time to seven minutes ...

ORLANDO, FL – Seven Indian American scientists were honored for their contributions by the Society of American Asian Scientists in Cancer Research (SAASCR) here. On April 16, during the American ...

This article is brought to you by our exclusive subscriber partnership with our sister title USA Today, and has been written by our American colleagues. It does not necessarily reflect the view of The ...

Nanotechnology is emerging as a transformative force in cancer research, but the future of precision oncology will not be defined by drug delivery alone. A new special issue of Cancer Biology & ...

Prayagraj: Motilal Nehru National Institute of Technology, in partnership with Central Bank of India, has launched Cyber Security Hackathon-2026, inviting students from IITs, NITs and other government ...

Scientists have developed smart polymeric nanoparticles that respond to unique signals within the tumor microenvironment to deliver immunotherapy precisely where needed. The approach overcomes a major ...